Latest News for: Societe pharma

Edit

On vaccines, the EU is getting what it paid for

The Spectator 25 Mar 2021
Much as the health commissioner Stella Kyriakides may dislike the first-come, first-served logic, pharma companies are in the business of making money for the shareholders, not serving the most pressing societal needs ... which pharma companies are understandably reluctant to do.
Edit

Why Enam’s Vallabh Bhanshali thinks 2021 Budget beats 1991 reforms

The Times of India 02 Feb 2021
Beginning with the vaccines, the next thrust is pharma. We were reverse manufacturing in pharma; now we are going to be front ending ... The PLI schemes can be really effective because every country has a natural advantage like in India you have a natural advantage towards IT, biology and pharma ... Pharma companies have another opportunity to go up.
Edit

Union Budget 2021: Covid-19 pandemic underlines need for higher allocation for healthcare sectorThe pharma industry ...

Deccan Herald 24 Jan 2021
The pharma sector which has played a leading role as the 'pharmacy of the world' said it expects support and incentives especially for research & development and innovation in the coming budget ... Emphasising expectations from the budget for the pharma sector, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
Edit

COVID-19 pandemic underlined need for higher budget allocation for healthcare sector

Yahoo Daily News 24 Jan 2021
The pharma sector which has played a leading role as the 'pharmacy of the world' said it expects support and incentives especially for research & development and innovation in the coming budget ... Emphasising expectations from the budget for the pharma sector, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
Edit

Covid vaccines offer chance for big pharma to improve its image

The Observer 04 Dec 2020
“Traditionally and historically, public trust in pharma has been comparable to the trust they put in their broadband provider,” said Alex Davies, a healthcare PR expert at Hanover Communications, which counts many drug companies as clients ... could 2020 mark a reputational turning point for big pharma?.
  • 1
×